SMS Pharmaceuticals Limited has submitted a report to the BSE Limited and the National Stock Exchange of India Ltd. regarding the Special Window for re-lodgement of transfer requests for physical shares, as per SEBI Circular No. SEBI/HO/MIRSD/MIRSD -PoD/P/CIR/2025/97 dated July 2, 2025.

The report, obtained from the Company's Registrar and Share Transfer Agent, M/s. Aarthi Consultants Private Limited, Hyderabad, covers the period from December 1, 2025, to January 6, 2026. It confirms that there were no requests received, processed, approved, or rejected during this period.

Consequently, the average time taken for processing requests is also NIL, as no actions were taken on any share transfer requests.